95740-49-1

Basic information

• Product Name: 4-BROMO-3-METHOXYPHENYL-P-TOLUENESULFONATE
• Synonyms: 4-BROMO-3-METHOXYPHENYL-P-TOLUENESULFONATE;1-bromo-2-methoxy-4-methylbenzene;Benzene,1-broMo-2-Methoxy-4-Methyl-
• CAS NO: 95740-49-1
• Molecular Formula: C₈H₉BrO
• Molecular Weight: 356.21
• Mol File: 95740-49-1.mol
• Article Data: 9

Chemical Properties

• Melting Point: 104-105℃
• Boiling Point: 107-109℃ (11 Torr)
• Flash Point: 104.227 °C
• Appearance: /
• Density: 1.378 g/cm³
• Vapor Pressure: 0.0919mmHg at 25°C
• Refractive Index: 1.535
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-BROMO-3-METHOXYPHENYL-P-TOLUENESULFONATE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-METHOXYPHENYL-P-TOLUENESULFONATE(95740-49-1)
• EPA Substance Registry System: 4-BROMO-3-METHOXYPHENYL-P-TOLUENESULFONATE(95740-49-1)

Safety Data

• Hazardous Substances Data: 95740-49-1(Hazardous Substances Data)

Usage

General Description

4-Bromo-3-methoxyphenyl-p-toluenesulfonate is a chemical compound that belongs to the class of organobromine compounds, which are organic compounds that contain bromine atoms. It typically appears as a crystalline solid and is used primarily in the field of organic chemistry, specifically in the synthesis of other complex molecules. The exact physical and chemical properties of this compound such as melting point, boiling point, toxicity, and reactivity might vary depending on the conditions under which it is stored or used. The compound's systematic name, according to the IUPAC nomenclature, suggests the presence of bromine (bromo), a methylated phenol ring (methoxyphenyl), and a toluenesulfonate group in the molecule.

InChI:InChI=1/C8H9BrO/c1-6-3-4-7(9)8(5-6)10-2/h3-5H,1-2H3

Upstream product

• 14847-51-9 2-bromo-5-methylphenol 
• 74-88-4 methyl iodide 
• 100-84-5 1-methoxy-3-methyl-benzene 
• 704-45-0 2-methoxy-4-methylbenzoic acid 
• 452-74-4 4-bromo-3-fluorotoluene 
• 124-41-4 sodium methylate 
• 38512-82-2 3-methoxy-4-nitrotoluene 
• 108-39-4 3-methyl-phenol 
• 22356-80-5 2-hydroxy-4-methylbenzenesulfonic acid 
• 77-78-1 dimethyl sulfate 
• 39538-68-6 2-methoxy-4-methylaniline 

Downstream Products

• 139102-35-5 1-(2-methoxy-4-methylphenyl)-2-nitropropene 
• 140221-61-0 (2-methoxy-4-methylphenyl)tributyl tin 
• 1148110-16-0 1-bromo-4-(bromomethyl)-2-methoxybenzene 
• 198211-79-9 (2-methoxy-4-methylphenyl)boronic acid 
• 1449700-79-1 lithium-2-(di-(2-methoxy-4-methyl-phenyl)phoshine)benzenesulfonate 
• 1449700-85-9 2-(di-(2-methoxy-4-methyl-phenyl)phoshine)benzenesulfonic acid 
• 1449700-88-2 bis{N,N’-{(κ2-P,O)-2-[di-(2-methoxy-4-methyl-phenyl)-phosphine]benzenesulfonate} palladium(II)-methyl}-N,N,N’,N’-tetramethylethylenediamine 
• 872373-69-8 2-[2,3'-bis(2-tert-butylocarbonylamino-ethyloxy)-biphenyl-4-ylmethyl]-isoindole-1,3-dione 
• 872373-79-0 C₂₁H₁₅NO₄ 

Relevant articles and documents

Micro reaction system and method for synthesizing 4-bromo-3-methylanisole through two-phase method

The invention discloses a micro reaction system and method for synthesizing 4-bromo-3-methylanisole through a two-phase method, and belongs to the technical field of chemical engineering. The micro reaction system comprises a micro mixer, a micro packed b

IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS HISTONE DEMETHYLASE INHIBITORS

This disclosure relates, inter alia, to compounds that inhibit histone demethylase activity. In particular, the disclosure relates to compounds that inhibit histone lysine demethylase KDM5B, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions disclosed herein.

NOVEL ANTIVIRAL COMPOUNDS

The present invention relates to compounds of formula (A) as defined herein having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having antiviral activity.